Global Huntington?s Disease Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 116 pages | ID: G6BA68A68B6GEN
GlobalInfoResearch

Abstracts

Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.

SCOPE OF THE REPORT:

This report studies the Huntington?s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Huntington?s Disease Treatment market by product type and applications/end industries.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
The global Huntington?s Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Huntington?s Disease Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Valeant Pharmaceuticals
• Teva Pharmaceuticals
• Wave Life Sciences
• Ionis Pharmaceuticals/ Roche
• Raptor Pharmaceuticals
• Prana Biotechnology

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Symptomatic Therapy
• Disease-Modifying Therapy

Market Segment by Applications, can be divided into

• Hospitals
• Ambulatory Surgical Centers

Contents

1 HUNTINGTON?S DISEASE TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Huntington?s Disease Treatment
1.2 Classification of Huntington?s Disease Treatment by Types
  1.2.1 Global Huntington?s Disease Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Huntington?s Disease Treatment Revenue Market Share by Types in 2017
  1.2.3 Symptomatic Therapy
  1.2.4 Disease-Modifying Therapy
1.3 Global Huntington?s Disease Treatment Market by Application
  1.3.1 Global Huntington?s Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
1.4 Global Huntington?s Disease Treatment Market by Regions
  1.4.1 Global Huntington?s Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Huntington?s Disease Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Huntington?s Disease Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Huntington?s Disease Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Huntington?s Disease Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Huntington?s Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Huntington?s Disease Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Valeant Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Huntington?s Disease Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Valeant Pharmaceuticals Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Huntington?s Disease Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Teva Pharmaceuticals Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Wave Life Sciences
  2.3.1 Business Overview
  2.3.2 Huntington?s Disease Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Wave Life Sciences Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ionis Pharmaceuticals/ Roche
  2.4.1 Business Overview
  2.4.2 Huntington?s Disease Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Ionis Pharmaceuticals/ Roche Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Raptor Pharmaceuticals
  2.5.1 Business Overview
  2.5.2 Huntington?s Disease Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Raptor Pharmaceuticals Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Prana Biotechnology
  2.6.1 Business Overview
  2.6.2 Huntington?s Disease Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Prana Biotechnology Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HUNTINGTON?S DISEASE TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Huntington?s Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Huntington?s Disease Treatment Players Market Share
  3.2.2 Top 10 Huntington?s Disease Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL HUNTINGTON?S DISEASE TREATMENT MARKET SIZE BY REGIONS

4.1 Global Huntington?s Disease Treatment Revenue and Market Share by Regions
4.2 North America Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HUNTINGTON?S DISEASE TREATMENT REVENUE BY COUNTRIES

5.1 North America Huntington?s Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE HUNTINGTON?S DISEASE TREATMENT REVENUE BY COUNTRIES

6.1 Europe Huntington?s Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HUNTINGTON?S DISEASE TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Huntington?s Disease Treatment Revenue by Countries (2013-2018)
7.2 China Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HUNTINGTON?S DISEASE TREATMENT REVENUE BY COUNTRIES

8.1 South America Huntington?s Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HUNTINGTON?S DISEASE TREATMENT BY COUNTRIES

9.1 Middle East and Africa Huntington?s Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL HUNTINGTON?S DISEASE TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Huntington?s Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Huntington?s Disease Treatment Market Forecast by Type (2018-2023)
10.3 Symptomatic Therapy Revenue Growth Rate (2013-2023)
10.4 Disease-Modifying Therapy Revenue Growth Rate (2013-2023)

11 GLOBAL HUNTINGTON?S DISEASE TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Huntington?s Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Huntington?s Disease Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)

12 GLOBAL HUNTINGTON?S DISEASE TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Huntington?s Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Huntington?s Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Huntington?s Disease Treatment Picture
Table Product Specifications of Huntington?s Disease Treatment
Table Global Huntington?s Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Huntington?s Disease Treatment Revenue Market Share by Types in 2017
Figure Symptomatic Therapy Picture
Figure Disease-Modifying Therapy Picture
Table Global Huntington?s Disease Treatment Revenue (Million USD) by Application (2013-2023)
Figure Huntington?s Disease Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Table Global Market Huntington?s Disease Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Huntington?s Disease Treatment Type and Applications
Table Valeant Pharmaceuticals Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Huntington?s Disease Treatment Type and Applications
Table Teva Pharmaceuticals Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Wave Life Sciences Basic Information, Manufacturing Base and Competitors
Table Wave Life Sciences Huntington?s Disease Treatment Type and Applications
Table Wave Life Sciences Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Pharmaceuticals/ Roche Basic Information, Manufacturing Base and Competitors
Table Ionis Pharmaceuticals/ Roche Huntington?s Disease Treatment Type and Applications
Table Ionis Pharmaceuticals/ Roche Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Raptor Pharmaceuticals Huntington?s Disease Treatment Type and Applications
Table Raptor Pharmaceuticals Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Prana Biotechnology Basic Information, Manufacturing Base and Competitors
Table Prana Biotechnology Huntington?s Disease Treatment Type and Applications
Table Prana Biotechnology Huntington?s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Huntington?s Disease Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Huntington?s Disease Treatment Revenue Share by Players (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Share by Players in 2016
Figure Global Huntington?s Disease Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Huntington?s Disease Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Huntington?s Disease Treatment Revenue Market Share in 2017
Figure Global Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Huntington?s Disease Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Huntington?s Disease Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Market Share by Regions in 2017
Figure North America Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure South America Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Table North America Huntington?s Disease Treatment Revenue by Countries (2013-2018)
Table North America Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Huntington?s Disease Treatment Revenue Market Share by Countries in 2017
Figure USA Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Table Europe Huntington?s Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Huntington?s Disease Treatment Revenue Market Share by Countries in 2017
Figure Germany Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure UK Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure France Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Huntington?s Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Huntington?s Disease Treatment Revenue Market Share by Countries in 2017
Figure China Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure India Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Table South America Huntington?s Disease Treatment Revenue by Countries (2013-2018)
Table South America Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Huntington?s Disease Treatment Revenue Market Share by Countries in 2017
Figure Brazil Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Huntington?s Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Huntington?s Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Huntington?s Disease Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Huntington?s Disease Treatment Revenue and Growth Rate (2013-2018)
Table Global Huntington?s Disease Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Huntington?s Disease Treatment Revenue Share by Type (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Share by Type (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Share by Type in 2017
Table Global Huntington?s Disease Treatment Revenue Forecast by Type (2018-2023)
Figure Global Huntington?s Disease Treatment Market Share Forecast by Type (2018-2023)
Figure Global Symptomatic Therapy Revenue Growth Rate (2013-2018)
Figure Global Disease-Modifying Therapy Revenue Growth Rate (2013-2018)
Table Global Huntington?s Disease Treatment Revenue by Application (2013-2018)
Table Global Huntington?s Disease Treatment Revenue Share by Application (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Share by Application (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue Share by Application in 2017
Table Global Huntington?s Disease Treatment Revenue Forecast by Application (2018-2023)
Figure Global Huntington?s Disease Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Huntington?s Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Huntington?s Disease Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Huntington?s Disease Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
Figure Europe Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
Figure South America Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Huntington?s Disease Treatment Revenue Market Forecast (2018-2023)